Pfizer CRZ 250 (Xalkori 250 mg)
Generic Name: crizotinib
Pill with imprint Pfizer CRZ 250 is Pink, Capsule-shape and has been identified as Xalkori 250 mg. It is supplied by Pfizer Inc..
Xalkori is used in the treatment of non-small cell lung cancer and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Xalkori 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Pfizer CRZ 250
Xalkori
- Generic Name:
- crizotinib
- Imprint:
- Pfizer CRZ 250
- Strength:
- 250 mg
- Color:
- Pink
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Multikinase inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Pfizer Inc.
- National Drug Code (NDC):
- 00069-8140
More about Xalkori (crizotinib)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 3 Reviews
- Drug class: multikinase inhibitors
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
